These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 2959643)
1. Teicoplanin and rifampicin singly and in combination in the treatment of experimental Staphylococcus epidermidis endocarditis in the rabbit model. Tuazon CU; Washburn D J Antimicrob Chemother; 1987 Aug; 20(2):233-7. PubMed ID: 2959643 [TBL] [Abstract][Full Text] [Related]
2. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis. Galetto DW; Boscia JA; Kobasa WD; Kaye D J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303 [TBL] [Abstract][Full Text] [Related]
4. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia. Shibl AM; Ishag AH; Durgham SM APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301 [TBL] [Abstract][Full Text] [Related]
5. Activity of teicoplanin in localized experimental infections in rats. Arioli V; Berti M; Candiani G J Hosp Infect; 1986 Mar; 7 Suppl A():91-9. PubMed ID: 2871103 [TBL] [Abstract][Full Text] [Related]
6. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421 [TBL] [Abstract][Full Text] [Related]
7. Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis. García-de-la-Mària C; Marco F; Armero Y; Soy D; Moreno A; del Río A; Almela M; Cervera C; Ninot S; Falces C; Mestres CA; Gatell JM; Jiménez de Anta MT; Miró JM; Antimicrob Agents Chemother; 2010 Jul; 54(7):2781-6. PubMed ID: 20421394 [TBL] [Abstract][Full Text] [Related]
8. Therapy for experimental endocarditis due to Staphylococcus epidermidis. Kobasa WD; Kaye KL; Shapiro T; Kaye D Rev Infect Dis; 1983; 5 Suppl 3():S533-7. PubMed ID: 6635444 [TBL] [Abstract][Full Text] [Related]
9. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus]. Apellaniz G; Valdés M; Pérez R; Martín-Luengo F; García A; Soria F; Gómez J Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):208-10. PubMed ID: 1830757 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of teicoplanin plus rifampicin in the treatment of bacteraemic infections caused by Staphylococcus aureus. Yzerman EP; Boelens HA; Vogel M; Verbrugh HA J Antimicrob Chemother; 1998 Aug; 42(2):233-9. PubMed ID: 9738842 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis. Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576 [TBL] [Abstract][Full Text] [Related]
12. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro. Claessens J; Roriz M; Merckx R; Baatsen P; Van Mellaert L; Van Eldere J Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358 [TBL] [Abstract][Full Text] [Related]
13. Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis. Kaatz GW; Seo SM; Dorman NJ; Lerner SA J Infect Dis; 1990 Jul; 162(1):103-8. PubMed ID: 2141343 [TBL] [Abstract][Full Text] [Related]
14. Association between daptomycin susceptibility and teicoplanin resistance in Staphylococcus epidermidis. Watanabe S; Kawakami Y; Kimura H; Murakami S; Miyamoto H; Takatori S; Suemori K; Tanaka M; Tanaka A; Tanaka K; Tauchi H; Maki J; Araki H; Yamaguchi T Sci Rep; 2019 Dec; 9(1):18533. PubMed ID: 31811214 [TBL] [Abstract][Full Text] [Related]
16. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy. Asseray N; Jacqueline C; Le Mabecque V; Batard E; Bugnon D; Potel G; Caillon J Antimicrob Agents Chemother; 2005 Feb; 49(2):857-9. PubMed ID: 15673789 [TBL] [Abstract][Full Text] [Related]
17. Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model. Baldoni D; Furustrand Tafin U; Aeppli S; Angevaare E; Oliva A; Haschke M; Zimmerli W; Trampuz A Int J Antimicrob Agents; 2013 Sep; 42(3):220-5. PubMed ID: 23880168 [TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters. Simon VC; Simon M Scand J Infect Dis Suppl; 1990; 72():14-9. PubMed ID: 2151061 [TBL] [Abstract][Full Text] [Related]